Olmesartan Medoxomil is used for the treatment of high blood pressure. The drug was developed by Sankyo (now known as Daiichi Sankyo). Money Control, 8 hours ago
NICE recommends blood-thinning drug edoxaban - European Pharmaceutical Review, 1 week ago
UK's NICE issues final guidance on Daiichi Sankyo's Lixiana for stroke and systemic embolism - Pharma Letter, 1 week ago
Innovative Medical Interactive Simulation Session to be presented at upcoming Continuing Education Company Education (CME) Conferences.
PRWeb Continuing Education Company (CEC) and Daiichi Sankyo Inc have awarded independent educational grants in support of an interaction simulation session entitled "NOACS: What the Evidence Shows in Managing AFib, Stroke Prevention and DVT/PE." ...Industrial Info Financials, 2 months ago
AstraZeneca (LSE: AZN) on Wednesday said it has partnered with Japanese drug major Daiichi Sankyo (TYO: 4568) to develop and market its influenza vaccine in Japan. The Anglo-Swedish drug major said it will receive an upfront payment from Daiichi ...Pharma Letter, 1 month ago Real world ETNA registries of new once-daily edoxaban start in Europe European Pharmaceutical Review, 1 month ago Daiichi Sankyo starts patient registration for new heart-condition drug in Europe Pharma Letter, 1 month ago
Release date- 31072015 - Tokyo, Japan - Daiichi Sankyo Company, Limited today announced a revision as follows to the 'Results Briefing (Results for Q1 FY2015)' materials originally disclosed at 1:00pm on Thursday , July 31, 2015 . Revised item ...4 Traders, 2 months ago
Mumbai: Malvinder Singh and Shivinder Singh, promoters of Religare Enterprise Ltd (REL), haven't been able to sell their stake in the financial services group because most potential buyers are interested in parts of the business, but reluctant to ...Livemint.com, 1 day ago Shivinder will always be by my side: Fortis cofounder Malvinder Mohan Singh Economic Times, 6 days ago Shivinder Mohan Singh of Fortis renounces business to join spiritual sect India TV, 1 week ago How's This For 'Sewa'? Fortis Owner Shivinder Singh Gives Up Rs 7500 Crore Empire Indiatimes, 1 week ago
More from: NDTV, Indiatimes...and 17 other sources
Goldman Sachs has taken a huge lead in the equity capital market league table for 2015. The US-based investment bank cornered 23 per cent market share, helping Indian companies raise $4.25 billion through six deals, data provided by Thomson Reuters ...Business Standard India, 4 days ago
Sold for $25m, reacquired for €340m ($379m), the ex-US rights for Kuvan and pegvaliase have returned to BioMarin Pharmaceutical (BMRN) as the company gears up for what it hopes will be a global launch for its most important value driver. The ...TeleTrader.com, 5 days ago
GlaxoSmithKline Pharmaceuticals (GSK) has strengthened its portfolio of cardiology drugs in Sri Lanka with the introduction of Benitec, the original Olmesartan Medoxomil developed by Daiichi-Sankyo, for the treatment of hypertension. Proven to ...DailyFT, 6 days ago
When it comes to what matters most in the workplace, are Millennials really that different from the rest of us? Among leaders, human resource managers and researchers, there seems to be no clear consensus. Some researchers have concluded those ...Business 2 Community, 6 days ago
Cardiovascular disease (CVD) and cancer have been the top killers in the industrialized world for years. But while the two are neck-and-neck, so to speak, for younger populations, CVD is the far-and-away primary cause of death for the elderly. Until ...Pharmaceutical Commerce, 6 days ago
on your WebpageAdd Widget >Get your members hooked!